ebomi
Colour theme
Sign in
Insider · CIK 0001682115

OrbiMed Capital GP VI LLC

CIK 0001682115 Name as filed on the most recent filing

Filed as OrbiMed Capital GP VI LLC (83)

200 transaction lines · from 83 filings · filed 2017-04-27 to 2026-04-23 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2021-03-12 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 2,741,881, disposed Open Form 4 filing 0000947871-21-000334
2021-03-11 S, Open-market sale Oric Pharmaceuticals, Inc.ORIC 1,934,525, disposed Open Form 4 filing 0000947871-21-000334
2021-03-01 S, Open-market sale SpringWorks Therapeutics, Inc.SWTX 101,491,800, disposed Open Form 4 filing 0000947871-21-000291
2021-01-07 S, Open-market sale CTI Biopharma CorpCTIC 7,000,000, disposed Open Form 4 filing 0000947871-21-000050
2020-12-28 S, Open-market sale Alpine Immune Sciences, Inc.ALPN 8,550,000, disposed Open Form 4 filing 0000947871-20-000981
2020-12-08 P, Open-market purchase Silverback Therapeutics, Inc.SBTX 2 lines 25,000,017, acquired Open Form 4 filing 0001209191-20-062387
2020-10-01 P, Open-market purchase LogicBio Therapeutics, Inc.LOGC 3 lines 8,888,892, acquired Open Form 4 filing 0000947871-20-000777
2020-09-25 P, Open-market purchase Prelude Therapeutics IncPRLD 2 lines 23,499,200, acquired Open Form 4 filing 0001209191-20-052404
2020-09-25 P, Open-market purchase Graybug Vision, Inc.GRAY 9,000,000, acquired Open Form 4 filing 0001209191-20-052342
2020-09-21 S, Open-market sale 89bio, Inc.ETNB 2 lines 7,700,000, disposed Open Form 4 filing 0000947871-20-000750
2020-05-21 P, Open-market purchase scPharmaceuticals Inc.SCPH 2 lines 11,999,998, acquired Open Form 4 filing 0000947871-20-000513
2020-04-24 P, Open-market purchase Oric Pharmaceuticals, Inc.ORIC 4,500,000, acquired Open Form 4 filing 0001209191-20-025990
2019-11-11 P, Open-market purchase 89bio, Inc.ETNB 2 lines 13,400,000, acquired Open Form 4 filing 0000899243-19-027217
2019-09-17 P, Open-market purchase SpringWorks Therapeutics, Inc.SWTX 4,950,000, acquired Open Form 4 filing 0001144204-19-045296
2019-06-24 P, Open-market purchase Prevail Therapeutics Inc.PRVL 14,999,984, acquired Open Form 4 filing 0001209191-19-039126
2019-05-13 P, Open-market purchase NextCure, Inc.NXTC 5,250,000, acquired Open Form 4 filing 0001123292-19-000748
2019-04-22 P, Open-market purchase Turning Point Therapeutics, Inc.TPTX 6,480,000, acquired Open Form 4 filing 0001209191-19-025794
2019-01-18 P, Open-market purchase Alpine Immune Sciences, Inc.ALPN 1,999,997, acquired Open Form 4 filing 0000947871-19-000043
2018-10-23 P, Open-market purchase LogicBio Therapeutics, Inc.LOGC 2 lines 11,900,000, acquired Open Form 4 filing 0000899243-18-027481
2018-08-30 S, Open-market sale SteadyMed Ltd.STDY 2 lines 18,938,034, disposed Open Form 4 filing 0000947871-18-000735
2018-07-23 P, Open-market purchase Constellation Pharmaceuticals IncCNST 2 lines 3,000,000, acquired Open Form 4 filing 0000899243-18-020515
2018-02-08 P, Open-market purchase Kala Pharmaceuticals, Inc.KALA 323,250, acquired Open Form 4 filing 0000947871-18-000123
2018-02-02 P, Open-market purchase Kala Pharmaceuticals, Inc.KALA 557,383, acquired Open Form 4 filing 0000947871-18-000106
2018-02-01 P, Open-market purchase Kala Pharmaceuticals, Inc.KALA 342,372, acquired Open Form 4 filing 0000947871-18-000094
2018-01-31 P, Open-market purchase Kala Pharmaceuticals, Inc.KALA 5,091,000, acquired Open Form 4 filing 0000947871-18-000094
2018-01-30 P, Open-market purchase resTORbio, Inc.TORC 7,999,995, acquired Open Form 4 filing 0000899243-18-002318
2018-01-29 P, Open-market purchase Kala Pharmaceuticals, Inc.KALA 749,500, acquired Open Form 4 filing 0000947871-18-000083
2018-01-26 P, Open-market purchase Kala Pharmaceuticals, Inc.KALA 339,807, acquired Open Form 4 filing 0000947871-18-000083
2018-01-24 P, Open-market purchase Kala Pharmaceuticals, Inc.KALA 963,738, acquired Open Form 4 filing 0000947871-18-000049
2018-01-23 P, Open-market purchase Kala Pharmaceuticals, Inc.KALA 65,401, acquired Open Form 4 filing 0000947871-18-000049
2018-01-22 P, Open-market purchase Kala Pharmaceuticals, Inc.KALA 1,123,500, acquired Open Form 4 filing 0000947871-18-000049
2018-01-19 P, Open-market purchase Kala Pharmaceuticals, Inc.KALA 1,120,218, acquired Open Form 4 filing 0000947871-18-000049
2018-01-12 P, Open-market purchase Kala Pharmaceuticals, Inc.KALA 438,068, acquired Open Form 4 filing 0000947871-18-000035
2018-01-12 P, Open-market purchase Kala Pharmaceuticals, Inc.KALA 556,133, acquired Open Form 4 filing 0000947871-18-000049
2018-01-11 P, Open-market purchase Kala Pharmaceuticals, Inc.KALA 569,205, acquired Open Form 4 filing 0000947871-18-000035
2018-01-10 P, Open-market purchase Kala Pharmaceuticals, Inc.KALA 2,185,437, acquired Open Form 4 filing 0000947871-18-000035
2017-11-21 P, Open-market purchase scPharmaceuticals Inc.SCPH 11,666,662, acquired Open Form 4 filing 0000899243-17-027185
2017-07-25 P, Open-market purchase Kala Pharmaceuticals, Inc.KALA 4,789,995, acquired Open Form 4 filing 0000947871-17-000581
2017-04-25 P, Open-market purchase SteadyMed Ltd.STDY 2 lines 6,926,600, acquired Open Form 4 filing 0000947871-17-000331

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. OrbiMed Capital GP VI LLC, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001682115

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.